Table 1.
Biochemical studies at initial presentation to the Yale Bone Center and following treatment with oral phosphate supplementation.
| serum Ca (mg/dl) (9.0–10.5) |
Serum Pi (mg/dl) (2.5–4.5) |
PTH (nleq/ml) (10–25) |
25- OHD (ng/ml) (20–45) |
1,25-OHD (ng/ml) (25–66) |
Alk Phos (U/L) (30–130) |
24hr urine Ca (mg) (100–300) |
TMP/GFR (mg/100ml GF) (2.5–4.2) |
|
|---|---|---|---|---|---|---|---|---|
| Before treatment |
9.6 | 1.5 | 7 | 39 | 222 | 426 | 328 | 1.95 |
| 2 months after treatment |
9.4 | 2.5 | 10 | 21 | 155 | 416 | ||
| 4 months after treatment |
9.4 | 9 | 47 | 212 | 389 | |||
| 15 months after treatment |
9.4 | 15 | 23 | 82 | 144 |